Vaccine Hesitancy
51
3
6
31
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
7.8%
4 terminated out of 51 trials
88.6%
+2.1% vs benchmark
0%
0 trials in Phase 3/4
23%
7 of 31 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 31 completed trials
Clinical Trials (51)
Predicting Vaccine Hesitancy Using Machine Learning
Effect of Primary Care Education on Parents' Health-Related Perceptions and Attitudes
Communication Strategies to Increase HPV Vaccination Intention
Addressing COVID-19 Vaccine Hesitancy With Muliti-Level Interventions in Appalachia
Increasing Vaccine Uptake Among Adolescents in the Rural South
Active Health Education to Increase HPV Vaccine Coverage in Youth: A Stepped-wedge, Cluster, and Randomized Trial
Motivational Interviewing for Vaccine Uptake in Latinx Adults
Brief Digital Intervention to Increase COVID-19 Vaccination Among Individuals With Anxiety or Depression
Improving Vaccine Acceptance Through EHR Integrated Patient- and Provider-Facing Decision Support
Vaccine Confidence Study Among Historically Marginalized Racial and Ethnic Groups
Multilevel Intervention of COVID-19 Vaccine Uptake Among Latinos
Impact of Supportive Vaccine Communication on Vaccine Desicion Processes
Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening
Thimble Mindfulness App and Recovery Patch Descriptions
Culturally and Linguistically Appropriate Vaccine Education
The Impact of a Web-based Psychoeducation Programme with a Motivational AI Chatbot on Covid-19 Vaccine Hesitancy
Improving Pediatric COVID-19 Vaccine Uptake Using an mHealth Tool
Dengue Vaccine Hesitancy Among International Travelers
ACTIVATE in Public Housing
COVID-19 Disease & Vaccine Survey in Africa